Etranacogene dezaparvovec-drlb gene therapy for patients with hemophilia B (congenital factor IX deficiency)
.
Source: Expert Opinion on Biological Therapy - Category: Drugs & Pharmacology Authors: Tro SekayanDana H. SimmonsAnnette von Drygalskia Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, San Diego, CA, USAb Capitol Scientific, Washington DC, USA Source Type: research
More News: Cancer & Oncology | Drugs & Pharmacology | Gene Therapy | Genetics | Haemophilia | Hematology | Hemophilia